These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30259686)

  • 21. [Normal tension glaucoma].
    Potop V; Dumitrache M; Ciocalteu A
    Oftalmologia; 2010; 54(2):11-4. PubMed ID: 20827906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between daytime variability of blood pressure or ocular perfusion pressure and glaucomatous visual field progression.
    Lee J; Choi J; Jeong D; Kim S; Kook MS
    Am J Ophthalmol; 2015 Sep; 160(3):522-537.e1. PubMed ID: 26052089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.
    Kim JM; Kim TW; Kim CY; Kim HK; Park KH
    Jpn J Ophthalmol; 2016 Jan; 60(1):20-6. PubMed ID: 26578422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent clinical pearls from clinical trials in glaucoma.
    Grover DS; Smith O
    Curr Opin Ophthalmol; 2012 Mar; 23(2):127-34. PubMed ID: 22249234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of novel laser speckle flowgraphy-derived variables of the large vessel area in the optic nerve head in normal tension glaucoma.
    Maekawa S; Shiga Y; Kawasaki R; Nakazawa T
    Clin Exp Ophthalmol; 2014 Dec; 42(9):887-9. PubMed ID: 24803413
    [No Abstract]   [Full Text] [Related]  

  • 26. 24-Hour Contact Lens Sensor Monitoring of Intraocular Pressure-Related Profiles in Normal-Tension Glaucoma and Rates of Disease Progression.
    Hoban K; Peden R; Megaw R; Halpin P; Tatham AJ
    Ophthalmic Res; 2017; 57(4):208-215. PubMed ID: 28171872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trabeculectomy for normal tension glaucoma: outcomes using the Moorfields Safer Surgery technique.
    Jayaram H; Strouthidis NG; Kamal DS
    Br J Ophthalmol; 2016 Mar; 100(3):332-8. PubMed ID: 26198279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postural response of intraocular pressure and visual field damage in patients with untreated normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    J Glaucoma; 2010 Mar; 19(3):191-3. PubMed ID: 19528820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of newly developed visual impairment in treated normal-tension glaucoma: 10-year follow-up.
    Choi YJ; Kim M; Park KH; Kim DM; Kim SH
    Acta Ophthalmol; 2014 Dec; 92(8):e644-9. PubMed ID: 24698142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular hypertension and normal-tension glaucoma: time for banishment and burial.
    Sommer A
    Arch Ophthalmol; 2011 Jun; 129(6):785-7. PubMed ID: 21670346
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased Intraocular Pressure in a Patient With Septooptic Dysplasia: A Case Report.
    Ulloa-Padilla JP; Izquierdo NJ; Oliver A
    J Glaucoma; 2016 Jul; 25(7):e713-7. PubMed ID: 27136085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glaucoma you may be missing. Sometimes normal eye pressures mask the condition.
    Harv Health Lett; 2013 Oct; 38(12):3. PubMed ID: 24432442
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results.
    Lee JW; Ho WL; Chan JC; Lai JS
    BMC Ophthalmol; 2015 Jan; 15():1. PubMed ID: 25571769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraocular pressure-lowering efficacy of dorzolamide/timolol fixed combination in normal-tension glaucoma.
    Kim TW; Kim M; Lee EJ; Jeoung JW; Park KH
    J Glaucoma; 2014; 23(5):329-32. PubMed ID: 23377586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma.
    Naito T; Okuma S; Nagayama M; Mizoue S; Ozaki M; Namiguchi K; Miyamoto K; Tanito M; Yoshikawa K
    Adv Ther; 2016 Mar; 33(3):435-46. PubMed ID: 26861847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Associated with Loss of Visual Function in Medically Treated Advanced Normal Tension Glaucoma.
    Kim S; Sung KR
    Curr Eye Res; 2017 Mar; 42(3):429-435. PubMed ID: 27420769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study.
    Kim M; Kim DM; Park KH; Kim TW; Jeoung JW; Kim SH
    Acta Ophthalmol; 2013 Jun; 91(4):e270-5. PubMed ID: 23406253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment.
    Sakata R; Aihara M; Murata H; Mayama C; Tomidokoro A; Iwase A; Araie M
    J Glaucoma; 2013 Mar; 22(3):250-4. PubMed ID: 23059475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large vessel area of the optic nerve head, measured with laser speckle flowgraphy, is significantly reduced in eyes with preperimetric glaucoma.
    Kiyota N; Shiga Y; Takahashi H; Nakazawa T
    Clin Exp Ophthalmol; 2015 Dec; 43(9):841-3. PubMed ID: 26100245
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of the extent of myopia on the progression of normal-tension glaucoma.
    Sohn SW; Song JS; Kee C
    Am J Ophthalmol; 2010 May; 149(5):831-8. PubMed ID: 20231010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.